XML 67 R52.htm IDEA: XBRL DOCUMENT v3.24.0.1
Note 8 - Accrued Expenses (Details Textual)
$ in Thousands
1 Months Ended 12 Months Ended
Nov. 01, 2024
USD ($)
Nov. 07, 2022
USD ($)
Jan. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Oct. 26, 2023
USD ($)
Interest Expense       $ 13,330 $ 11,592 $ 12,807  
Restructuring, Percentage of Reduction in Headcount             5.00%
Employee Severance [Member]              
Restructuring and Related Cost, Cost Incurred to Date             $ 400
Deferred Compensation Arrangement with Individual, Compensation Expense       100      
Eshelman v. Puma Biotechnology, Inc. [Member]              
Interest Expense       7,700 15,400    
Payments for Legal Settlements     $ 8,000 $ 8,000 $ 16,000    
Litigation Settlement, Amount Awarded to Other Party   $ 16,000          
Legal Settlements Payments, Number of Installments   2   2      
Eshelman v. Puma Biotechnology, Inc. [Member] | Forecast [Member]              
Payments for Legal Settlements $ 8,000